{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:41:12Z","timestamp":1793400072494,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.tcm.2026.01.001","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:28:00Z","timestamp":1768350480000},"page":"307-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Parkinson\u2019s disease & cardiovascular disease: A narrative review"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8933-5001","authenticated-orcid":false,"given":"Alexander","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyla","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergi","family":"Duli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souzan","family":"Yacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Meghdadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Langleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Juan","family":"Baratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Arauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-6569","authenticated-orcid":false,"given":"Adrian","family":"Baranchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.tcm.2026.01.001_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612601","article-title":"Clinical and non-Clinical cardiovascular disease associated pathologies in Parkinson\u2019s disease","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.tcm.2026.01.001_bib0002","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/1073858421990000","article-title":"Heart matters: cardiac dysfunction and other autonomic changes in Parkinson\u2019s disease","volume":"28","author":"Gon\u00e7alves","year":"2022","journal-title":"Neuroscientist"},{"key":"10.1016\/j.tcm.2026.01.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117172","article-title":"Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: the Japanese Quality-of-life Survey of Parkinson Disease (JAQPAD) study","volume":"419","author":"Kurihara","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.tcm.2026.01.001_bib0004","first-page":"25","volume":"18","author":"Grosu","year":"2023","journal-title":"Parkinson\u2019s Dis. Cardiovasc. Involv.: Edifying Insights (Rev.). Biomed. Rep."},{"issue":"8","key":"10.1016\/j.tcm.2026.01.001_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41569-025-01140-3","article-title":"The brain\u2013heart axis: integrative cooperation of neural, mechanical and biochemical pathways","volume":"22","author":"Valenza","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.tcm.2026.01.001_bib0006","article-title":"Cardiovascular outcomes in Parkinson\u2019s disease patients from a retrospective cohort study","volume":"14","author":"Lim","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.tcm.2026.01.001_bib0007","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/ene.14076","article-title":"Does Parkinson\u2019s disease increase the risk of cardiovascular events? A systematic review and meta-analysis","volume":"27","author":"Alves","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tcm.2026.01.001_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2018.04.031","article-title":"Cardiac abnormalities in Parkinson\u2019s disease and Parkinsonism","volume":"53","author":"Scorza","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.tcm.2026.01.001_bib0009","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/CLEP.S163493","article-title":"Prevalent cerebrovascular and cardiovascular disease in people with Parkinson\u2019s disease: a meta-analysis","volume":"10","author":"Hong","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.tcm.2026.01.001_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1284826","article-title":"Association between Parkinson\u2019s disease and the risk of adverse cardiovascular events: a systematic review and meta-analysis","volume":"10","author":"Hu","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.tcm.2026.01.001_bib0011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mds.27836","article-title":"Understanding the links between cardiovascular disease and Parkinson\u2019s Disease","volume":"35","author":"Potashkin","year":"2020","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.tcm.2026.01.001_bib0012","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3233\/JPD-212670","article-title":"Blood cholesterol decreases as Parkinson\u2019s Disease develops and progresses","volume":"11","author":"Wang","year":"2021","journal-title":"J. Parkinsons. Dis."},{"issue":"7","key":"10.1016\/j.tcm.2026.01.001_bib0013","first-page":"421","article-title":"Glycaemic control and cardiovascular disease: is there a light at the end of the tunnel?","volume":"110","author":"Knobler","year":"2017","journal-title":"QJM"},{"issue":"18","key":"10.1016\/j.tcm.2026.01.001_bib0014","doi-asserted-by":"crossref","first-page":"e3549","DOI":"10.1097\/MD.0000000000003549","article-title":"Risk of Parkinson disease in diabetes mellitus","volume":"95","author":"Yue","year":"2016","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.tcm.2026.01.001_bib0015","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.tcm.2026.01.001_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mad.2016.09.006","article-title":"Effect of glycation inhibitors on aging and age-related diseases","volume":"160","author":"Sadowska-Bartosz","year":"2016","journal-title":"Mech. Ageing Dev."},{"issue":"5","key":"10.1016\/j.tcm.2026.01.001_bib0017","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/brain\/awx056","article-title":"Glycation potentiates \u03b1-synuclein-associated neurodegeneration in synucleinopathies","volume":"140","author":"H","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.tcm.2026.01.001_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/924860","article-title":"Arginase as a critical prooxidant mediator in the binomial endothelial dysfunction-atherosclerosis","volume":"2015","author":"Rabelo","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"issue":"7","key":"10.1016\/j.tcm.2026.01.001_bib0019","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/antiox9070597","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"9","author":"Chang","year":"2020","journal-title":"Antioxidants"},{"issue":"21","key":"10.1016\/j.tcm.2026.01.001_bib0020","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma ceramides, Mediterranean diet, and incident cardiovascular disease in the PREDIMED trial (Prevenci\u00f3n con Dieta Mediterr\u00e1nea)","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.tcm.2026.01.001_bib0021","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tem.2018.11.003","article-title":"Sphingolipids in the pathogenesis of Parkinson\u2019s disease and Parkinsonism","volume":"30","author":"Lin","year":"2019","journal-title":"Trends. Endocrinol. Metab."},{"key":"10.1016\/j.tcm.2026.01.001_bib0022","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnins.2019.00328","article-title":"Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease","volume":"13","author":"Alecu","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tcm.2026.01.001_bib0023","first-page":"219","article-title":"Circulating cholesterol levels may link to the factors influencing Parkinson\u2019s","volume":"8","author":"Zhang","year":"2017","journal-title":"Risk Front Neurol."},{"key":"10.1016\/j.tcm.2026.01.001_bib0024","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Joers V. Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.tcm.2026.01.001_bib0025","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/193229681000400326","article-title":"High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with Pioglitazone","volume":"4","author":"Pf\u00fctzner","year":"2010","journal-title":"J. Diabetes. Sci. Technol."},{"issue":"14","key":"10.1016\/j.tcm.2026.01.001_bib0026","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.119.044948","article-title":"Association of Parkinson Disease with risk of cardiovascular disease and all-cause mortality","volume":"141","author":"Park","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.01.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: implications for pathophysiology, diagnosis, and treatment","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.tcm.2026.01.001_bib0028","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s13760-019-01113-7","article-title":"Nocturnal blood pressure changes in Parkinson\u2019s disease: correlation with autonomic dysfunction and vitamin D levels","volume":"120","author":"Arici Duz","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.tcm.2026.01.001_bib0029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","article-title":"Orthostatic hypotension in Parkinson Disease","volume":"36","author":"Palma","year":"2020","journal-title":"Clin. Geriatr. Med."},{"issue":"10","key":"10.1016\/j.tcm.2026.01.001_bib0030","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Park. Relat. Disord"},{"key":"10.1016\/j.tcm.2026.01.001_bib0031","first-page":"64","article-title":"The management of orthostatic hypotension in Parkinson\u2019s","volume":"4","author":"S\u00e1nchez-Ferro","year":"2013","journal-title":"Dis. Front. Neurol."},{"key":"10.1016\/j.tcm.2026.01.001_bib0032","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10286-017-0440-8","article-title":"Postprandial hypotension in neurological disorders: systematic review and meta-analysis","volume":"27","author":"Paveli\u0107","year":"2017","journal-title":"Clin. Aut. Res."},{"issue":"2","key":"10.1016\/j.tcm.2026.01.001_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10286-015-0270-5","article-title":"Non-dipping nocturnal blood pressure and psychosis parameters in Parkinson disease","volume":"25","author":"Stuebner","year":"2015","journal-title":"Clin. Aut. Res."},{"key":"10.1016\/j.tcm.2026.01.001_bib0034","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","article-title":"Clinical characteristics of supine hypertension in de novo Parkinson disease","volume":"26","author":"Umehara","year":"2016","journal-title":"Clin. Aut. Res."},{"issue":"1","key":"10.1016\/j.tcm.2026.01.001_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/01616412.2017.1390933","article-title":"Structural and functional alterations of the heart in Parkinson\u2019s disease","volume":"40","author":"Piqueras-Flores","year":"2018","journal-title":"Neurol. Res."},{"issue":"5","key":"10.1016\/j.tcm.2026.01.001_bib0036","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/08919887211060017","article-title":"Orthostatic hypotension and antiparkinsonian drugs: a systematic review and meta-analysis","volume":"35","author":"Nimmons","year":"2021","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"1","key":"10.1016\/j.tcm.2026.01.001_bib0037","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16061","article-title":"Levodopa-induced orthostatic hypotension in parkinsonism: a red flag of autonomic failure","volume":"31","author":"Cani","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tcm.2026.01.001_bib0038","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/VHRM.S53983","article-title":"Neurogenic orthostatic hypotension in Parkinson\u2019s disease: evaluation, management, and emerging role of droxidopa","volume":"10","author":"Isaacson","year":"2014","journal-title":"Vasc. Health Risk. Manage."},{"issue":"6","key":"10.1016\/j.tcm.2026.01.001_bib0039","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3233\/JPD-223291","article-title":"Association between Parkinson\u2019s Disease and coronary artery Disease: a systematic review and meta-analysis","volume":"12","author":"Chua","year":"2022","journal-title":"J. Parkinsons. Dis."},{"issue":"5","key":"10.1016\/j.tcm.2026.01.001_bib0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1017\/cjn.2018.56","article-title":"Stroke and coronary artery disease are associated with Parkinson\u2019s disease","volume":"45","author":"Li","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.tcm.2026.01.001_bib0041","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/metabo12040312","article-title":"Cardiovascular\/stroke risk stratification in Parkinson\u2019s Disease patients using atherosclerosis pathway and artificial intelligence paradigm: a systematic review","volume":"12","author":"Suri","year":"2022","journal-title":"Metabolites."},{"key":"10.1016\/j.tcm.2026.01.001_bib0042","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fneur.2019.00022","article-title":"Association between Parkinson\u2019s Disease and atrial fibrillation: a population-based study","volume":"10","author":"Hong","year":"2019","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.tcm.2026.01.001_bib0043","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/mds.24979","article-title":"Cardiovascular physiology in premotor Parkinson\u2019s disease: a neuroepidemiologic study","volume":"27","author":"Jain","year":"2012","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.tcm.2026.01.001_bib0044","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/ene.16110","article-title":"Parkinson\u00b4s disease cardiovascular symptoms: a new complex functional and structural insight","volume":"31","author":"Kincl","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.tcm.2026.01.001_bib0045","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11239-023-02792-z","article-title":"Atrial fibrillation risk on Parkinson\u2019s disease \u2013 a systematic review and meta-analysis","volume":"55","author":"Cereja","year":"2023","journal-title":"J. Thromb. Thrombolysis."},{"issue":"4","key":"10.1016\/j.tcm.2026.01.001_bib0046","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3233\/JPD-171209","article-title":"Domperidone for hypotension in Parkinson\u2019s Disease: a systematic review","volume":"7","author":"Bacchi","year":"2017","journal-title":"J. Parkinsons. Dis."},{"issue":"3","key":"10.1016\/j.tcm.2026.01.001_bib0047","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00210-020-02028-4","article-title":"Donepezil induces ventricular arrhythmias by delayed repolarisation","volume":"394","author":"Kho","year":"2021","journal-title":"Naunyn. Schmiedeb. Arch. Pharmacol."},{"issue":"9","key":"10.1016\/j.tcm.2026.01.001_bib0048","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/qjmed\/hcu024","article-title":"Parkinson\u2019s disease and pseudo-ventricular tachycardia","volume":"107","author":"Sawhney","year":"2014","journal-title":"QJM"},{"issue":"12","key":"10.1016\/j.tcm.2026.01.001_bib0049","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40263-015-0293-4","article-title":"Risks of cardiac valve regurgitation and heart failure associated with ergot- and non-ergot-derived dopamine agonist use in patients with Parkinson\u2019s Disease: a systematic Review of Observational Studies","volume":"29","author":"Tran","year":"2015","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.tcm.2026.01.001_bib0050","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/jpm13091357","article-title":"The Association between Parkinson\u2019s Disease and Congestive Heart Failure in Korea: a nationwide longitudinal cohort study","volume":"13","author":"Kim","year":"2023","journal-title":"J. Pers. Med."},{"issue":"4","key":"10.1016\/j.tcm.2026.01.001_bib0051","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.25564","article-title":"Associations between cerebrovascular risk factors and parkinson disease","volume":"86","author":"Kummer","year":"2019","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.tcm.2026.01.001_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1063","article-title":"Pros and cons for statins use and risk of Parkinson\u2019s disease: an updated perspective","volume":"11","author":"Al-kuraishy","year":"2023","journal-title":"Pharmacol. Res. Perspect."}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173826000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173826000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:48:46Z","timestamp":1780588126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173826000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1050173826000071"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2026.01.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson\u2019s disease & cardiovascular disease: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2026.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}